Venture studioYVLabs is a biotechnology and digital health venture studio that creates AI-enabled startups focused on drug design and medical diagnostics. Operating internationally, it leverages deep learning and blockchain technologies.

82VS is a Boston-based venture studio affiliated with Alloy Therapeutics, focusing on building biotech companies that develop innovative therapeutics in various disease areas.
Online destinations
Public destinations are grouped by their documented relationship to the organization. A listed link does not by itself prove ownership or control.
Destinations the organization presents as part of its public presence.
82VS is a venture studio dedicated to the development of innovative treatments in the biotech sector. Founded to support the creation of drug companies, it collaborates with a diverse range of partners, including academics, entrepreneurs, and pharmaceutical firms. Based in the United States, 82VS emphasizes capital efficiency in its operations.
The organization invests in the biotechnology sector, particularly in drug discovery and development. 82VS focuses on various modalities, including antibodies, bispecifics, TCR mimics, and genetic medicines, leveraging its partnership with Alloy Therapeutics to provide advanced discovery platforms and services.
82VS offers mentorship, access to advanced discovery platforms, R&D funding, and strategic partnerships to support early-stage biotech companies from concept to Series A.
Q: What is the focus of 82VS? A: 82VS focuses on building capital-efficient biotech companies in drug discovery and development. Q: How can I engage with 82VS? A: Interested parties can reach out through the contact page on their website.
Superscout Pro

Superscout documents 82VS independently from canonical records and linked sources. Missing facts stay missing.
Last reviewed .
Terms, dates, and eligibility can change. Confirm time-sensitive details with the original source.
Stage and region classifications are shown as recorded. Broad labels such as “Global” and category-like stage labels may still need normalization.
Superscout is not affiliated with, endorsed by, or acting on behalf of the organizations documented here.